Hexylcaine
4883632
161053229
2007-09-29T04:01:33Z
Shoy
459990
Fixing image for image move to commons
{{drugbox
| IUPAC_name = 1-cyclohexylaminopropan-2-yl benzoate
| image = Hexylcaine.PNG
| CAS_number = 532-77-4
| ATC_prefix =
| ATC_suffix =
| ATC_supplemental =
| PubChem = 10770
| DrugBank = APRD01014
| C = 16 | H = 23 | N = 1 | O = 2
| molecular_weight = 261.359 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life = <10 minutes
| pregnancy_category =
| legal_status =
| routes_of_administration =
}}
'''Hexylcaine hydrochloride''', also called '''cyclaine''' ([[Merck & Co.|Merck]]) or '''osmocaine''', is a short-acting [[local anesthetic]]. It acts by inhibiting [[sodium channel]] conduction. Overdose can lead to [[headache]], [[tinnitus]], [[paresthesia|numbness and tingling]] around the mouth and tongue, [[convulsion]]s, [[respiratory arrest|inability to breathe]], and decreased heart function.
{{Local anesthetics}}
[[Category:Local anesthetics]]
{{pharma-stub}}